Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Chelsea Therapeutics International Ltd CHTP

Healthcare Biotechnology

Recent & Breaking News (NDAQ:CHTP)

Lundbeck to Acquire Chelsea Therapeutics

GlobeNewswire May 8, 2014

Throwback Thursday: Cold War-esque Tensions Send Stocks Plummeting

Equities.com March 13, 2014

Chelsea Therapeutics Reports Fourth Quarter and Full-Year 2013 Results

GlobeNewswire March 11, 2014

Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day

GlobeNewswire February 28, 2014

Judge Approves Lehman Brothers $767M Settlement; Arrowhead Research Hits New 52-week High

Accesswire February 20, 2014

Chelsea Therapeutics (CHTP) Spikes on FDA Announcement

Equities.com February 19, 2014

Housing Data and Fed Minutes Send Wall Street Lower

Equities.com February 19, 2014

Chelsea Therapeutics’ (CHTP) Northera wins ‘accelerated approval’ by FDA

Stockhouse Editorial February 18, 2014

Chelsea Therapeutics Announces FDA Accelerated Approval of NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic NOH

Business Wire February 18, 2014

Stocks Rally For Another Up Week on Wall Street

Equities.com February 14, 2014

Chelsea Therapeutics Issues Statement Regarding Postponement of NORTHERA(TM) (Droxidopa) NDA PDUFA Action Date Due to Severe Weather

GlobeNewswire February 14, 2014

Chelsea Therapeutics Names Keith W. Schmidt Chief Commercial Officer

Globe Newswire January 30, 2014

Real Good Solar Takes On New Name, Ticker Symbol and Strategy: Real Goods Solar Inc. (NASDAQ:RSOL), Atossa Genetics Inc. (NASDAQ: ATOS), Chelsea Therapeutics International, Ltd. (NASDAQ:CHTP)

Accesswire January 28, 2014

Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director

Globe Newswire January 27, 2014

Five Star Equities Issues New Research Reports on CHTP, DRWI, DTLK and NQ

Accesswire January 16, 2014

Opening Buzzers: Chelsea Therapeutics International, Tesla Motors Inc, NQ Mobile Inc, Rexahn Pharmaceuticals

Accesswire January 15, 2014

FDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOH

Globe Newswire January 14, 2014

Five Star Equities Issues New Research Reports on ANGO, CHTP, FRAN and YRCW

Accesswire January 13, 2014

TrendingWallStreet.com Releases Trend Reports on DM, CHTP, BZNE, and BGMD

Accesswire January 6, 2014

Chelsea Therapeutics Announces First Patient Dosed in NORTHERA(TM) (droxidopa) Study 401 for the Treatment of Symptomatic nOH

Globe Newswire December 9, 2013